Ariel Investments LLC increased its holdings in Digirad Co. (NASDAQ:DRAD) by 91.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,222,819 shares of the medical equipment provider’s stock after acquiring an additional 584,777 shares during the period. Ariel Investments LLC owned approximately 6.10% of Digirad worth $3,149,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of DRAD. Goldman Sachs Group Inc. lifted its stake in Digirad by 24.2% during the second quarter. Goldman Sachs Group Inc. now owns 42,810 shares of the medical equipment provider’s stock worth $173,000 after purchasing an additional 8,347 shares in the last quarter. Macquarie Group Ltd. acquired a new stake in shares of Digirad in the third quarter valued at $367,000. New York State Common Retirement Fund acquired a new stake in shares of Digirad in the second quarter valued at $574,000. Finally, Heartland Advisors Inc. raised its stake in shares of Digirad by 10.0% in the fourth quarter. Heartland Advisors Inc. now owns 970,605 shares of the medical equipment provider’s stock valued at $2,499,000 after acquiring an additional 88,134 shares in the last quarter. Institutional investors own 56.14% of the company’s stock.
In other Digirad news, major shareholder Cannell Capital Llc bought 65,508 shares of Digirad stock in a transaction that occurred on Tuesday, January 23rd. The shares were acquired at an average price of $2.65 per share, for a total transaction of $173,596.20. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Matthew G. Molchan bought 25,000 shares of Digirad stock in a transaction that occurred on Wednesday, February 28th. The shares were acquired at an average price of $2.14 per share, for a total transaction of $53,500.00. Following the acquisition, the insider now directly owns 77,819 shares in the company, valued at approximately $166,532.66. The disclosure for this purchase can be found here. 9.10% of the stock is currently owned by insiders.
Shares of NASDAQ DRAD traded down $0.05 during midday trading on Monday, reaching $1.50. 49,797 shares of the company were exchanged, compared to its average volume of 71,373. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.51 and a quick ratio of 1.18. Digirad Co. has a 1 year low of $1.50 and a 1 year high of $5.45.
Digirad (NASDAQ:DRAD) last announced its quarterly earnings data on Friday, February 23rd. The medical equipment provider reported ($0.14) EPS for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.19). The firm had revenue of $30.92 million during the quarter. Digirad had a negative net margin of 30.19% and a positive return on equity of 0.32%.
Separately, ValuEngine lowered Digirad from a “buy” rating to a “hold” rating in a report on Sunday, December 31st.
WARNING: This piece was posted by Enterprise Leader and is the property of of Enterprise Leader. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://theenterpriseleader.com/2018/04/02/ariel-investments-llc-increases-holdings-in-digirad-co-drad.html.
Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services.
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.